Correlation Between Genix Pharmaceuticals and Cannabis Suisse
Can any of the company-specific risk be diversified away by investing in both Genix Pharmaceuticals and Cannabis Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genix Pharmaceuticals and Cannabis Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genix Pharmaceuticals and Cannabis Suisse Corp, you can compare the effects of market volatilities on Genix Pharmaceuticals and Cannabis Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genix Pharmaceuticals with a short position of Cannabis Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genix Pharmaceuticals and Cannabis Suisse.
Diversification Opportunities for Genix Pharmaceuticals and Cannabis Suisse
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Genix and Cannabis is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Genix Pharmaceuticals and Cannabis Suisse Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Suisse Corp and Genix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genix Pharmaceuticals are associated (or correlated) with Cannabis Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Suisse Corp has no effect on the direction of Genix Pharmaceuticals i.e., Genix Pharmaceuticals and Cannabis Suisse go up and down completely randomly.
Pair Corralation between Genix Pharmaceuticals and Cannabis Suisse
Assuming the 90 days horizon Genix Pharmaceuticals is expected to generate 1.52 times less return on investment than Cannabis Suisse. But when comparing it to its historical volatility, Genix Pharmaceuticals is 2.25 times less risky than Cannabis Suisse. It trades about 0.15 of its potential returns per unit of risk. Cannabis Suisse Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 1.43 in Cannabis Suisse Corp on August 11, 2025 and sell it today you would lose (0.70) from holding Cannabis Suisse Corp or give up 48.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 98.48% |
| Values | Daily Returns |
Genix Pharmaceuticals vs. Cannabis Suisse Corp
Performance |
| Timeline |
| Genix Pharmaceuticals |
| Cannabis Suisse Corp |
Genix Pharmaceuticals and Cannabis Suisse Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genix Pharmaceuticals and Cannabis Suisse
The main advantage of trading using opposite Genix Pharmaceuticals and Cannabis Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genix Pharmaceuticals position performs unexpectedly, Cannabis Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Suisse will offset losses from the drop in Cannabis Suisse's long position.| Genix Pharmaceuticals vs. Textmunication Holdings | Genix Pharmaceuticals vs. Indo Global Exchange | Genix Pharmaceuticals vs. Khiron Life Sciences | Genix Pharmaceuticals vs. Kaya Holdings |
| Cannabis Suisse vs. Elixinol Global | Cannabis Suisse vs. Nutra Pharma Corp | Cannabis Suisse vs. Pure Harvest Cannabis | Cannabis Suisse vs. Stem Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |